Lipoprotein A (LPA) ELISA Kits

The protein encoded by LPA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. Additionally we are shipping LPA Antibodies (38) and and many more products for this protein.

list all ELISA KIts Gene Name GeneID
LPA 4018
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top LPA ELISA Kits at

Showing 10 out of 24 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Delivery Price Details
  96 Tests 2 to 3 Days
Mouse 0.46 ng/mL 1.56 ng/mL - 100 ng/mL Typical Standard Curve 96 Tests 15 to 17 Days
Rat 1.0 pg/mL 250-5000 pg/mL   96 Tests 15 to 18 Days
Guinea Pig 1.0 ng/mL 5.0-100 ng/mL   96 Tests 15 to 18 Days
Rabbit 1.0 ng/mL 5.0-100 ng/mL   96 Tests 15 to 18 Days
Monkey 1.0 pg/mL 250-5000 pg/mL   96 Tests 15 to 18 Days
  96 Tests 15 to 18 Days
Dog 1.0 ng/mL 5.0-100 ng/mL   96 Tests 15 to 18 Days
  96 Tests 15 to 18 Days
  96 Tests 15 to 18 Days

More ELISA Kits for LPA Interaction Partners

Human Lipoprotein A (LPA) interaction partners

  1. Lp(a) molar/mass ratios are threshold, method, and isoform dependent

  2. Meta-analysis: Genetic variations at the LPA locus are associated with CHD events during statin therapy independently of the extent of low-density lipoprotein cholesterol lowering.

  3. Lp(a) accelerates progression of atherosclerosis in these individuals, thereby contributing to their increased ASCVD risk

  4. Proinflammatory interleukin 1 (IL-1(+)) genotypes modulate the risk of Lp(a) long-term cardiovascular disease (CVD) events and coronary artery disease (CAD).

  5. The autors results confirm the association between LPA SNPs rs10455872 and rs3798220 with AS and demonstrated that individuals with 2 risk alleles have a 2-fold or greater odds of developing AS.

  6. The LPA 9p21 locus was associated with risk of aortic valve stenosis.

  7. High lipoprotein(a) levels were associated with a higher incidence of major adverse limb events after endovascular treatment for patients with aortoiliac lesions.

  8. In a multiethnic sample, Lp(a)-related risks of heart failure were only evident in white participants.

  9. High plasma lipoprotein a levels accelerated the progression of atherosclerosis in end-stage renal disease through lipoprotein a accumulation in the arteries.

  10. The population differences in Lp(a) concentrations between Finnish and Central European populations originate not only from a different LPA isoform distribution but suggest the existence of novel functional variation in the small-isoform range.

  11. Elevated lipoprotein(a) concentrations were independently associated with an increased risk of abdominal aortic aneurysms.

  12. Lp(a) seems to be an independent risk factor for acute coronary syndromes in individuals <45 years, and high Lp(a) levels increase by approximately 3folds the risk for ACS. The association is preserved but is less in middle-aged individuals (45-60 years) and is abolished >60 years.

  13. Common p2y13 polymorphisms are associated with plasma inhibitory factor 1 and lipoprotein(a) concentrations, heart rate and body fat mass and may modulate cardiovascular risk.

  14. Elevated Lp(a) levels were independently associated with the presence and severity of coronary artery disease in patients with type 2 diabetes.

  15. pplication of system Lipoprint (Quantimetrix USA) provides no opportunity to unequivocally interpret data concerning input of sub-fractions of lipoproteins into risk of development of cardio-vascular diseases in patients with pathological lipid profile and higher concentration of lipoprotein (a).

  16. Elevated Lp(a) levels were independent predictors of increases in carotid atherosclerosis burden.

  17. The common variant rs12740374 associated with Lp(a) cholesterol is a quantitative trait locus for SORT1 which is independent of LDL cholesterol.

  18. elevated serum Lp(a) levels can predict the risk of early stroke recurrence in patients with first-ever ischemic stroke.

  19. Letter/Meta-analysis: lipoprotein(a) SNP rs10455872 is with aortic stenosis risk.

  20. Apo(a) attenuates cell-surface plasmin-mediated conversion of Glu- to Lys-plasminogen.

LPA Antigen Profile

Antigen Summary

The protein encoded by this gene is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The encoded protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the encoded protein contains 2-43 copies of kringle-type domains. The allele represented here contains 15 copies of the kringle-type repeats and corresponds to that found in the reference genome sequence.

Gene names and symbols associated with Lipoprotein A (LPA) ELISA Kits

  • lipoprotein(a) (LPA) antibody
  • coagulation factor II, thrombin S homeolog (f2.S) antibody
  • AK38 antibody
  • APOA antibody
  • LP antibody
  • LPA antibody
  • MGC82169 antibody

Protein level used designations for Lipoprotein A (LPA) ELISA Kits

antiangiogenic AK38 protein , apo(a) , apolipoprotein(a) , lp(a) , lipoprotein, Lp(a) , apolipoprotein(a)-like

4018 Homo sapiens
446352 Xenopus laevis
463116 Pan troglodytes
100439959 Pongo abelii
Selected quality suppliers for LPA (LPA) ELISA Kits
Did you look for something else?